Glenmark Life Sciences Listing Strategy

Continue with Glenmark Life Sciences dosage in your portfolio, despite muted listing

Glenmark Life Sciences got listed at price to earnings of 26.01x compared to Divis Lab & Laurus Lab which are trading at 65.8x & 34.2x, respectively.